Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response
The American Journal of Pathology · 2026-09 · 196 (9) · 1837-1838
DOI: 10.1016/j.ajpath.2026.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2026-09. Verfasst von Hussein N Yassine. Beteiligte Einrichtung: Neurology and Department of Physiology and Neuroscience, Keck School of Medicine of USC, Los Angeles, California. Electronic address: hyassine@usc.ed…. Die Arbeit nennt 5 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Neurology and Department of Physiology and Neuroscience, Keck School of Medicine of USC, Los Angeles, California. Electronic address: hyassine@usc.edu.
Zitieren
APA
Yassine, H. N. (2026). Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response. The American Journal of Pathology, 196(9), 1837-1838. https://doi.org/10.1016/j.ajpath.2026.06.003
Vancouver
Yassine HN. Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response. The American Journal of Pathology. 2026;196(9):1837-1838. doi:10.1016/j.ajpath.2026.06.003
BibTeX
@article{Yassine2026,
author = {Yassine, Hussein N},
title = {Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response},
journal = {The American Journal of Pathology},
year = {2026},
volume = {196},
number = {9},
pages = {1837--1838},
doi = {10.1016/j.ajpath.2026.06.003}
}
EUVIMED